High Vista Strategies LLC Ideaya Biosciences, Inc. Transaction History

High Vista Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$34.37 - $43.46 $2.01 Million - $2.54 Million	-58,436 Reduced 58.85%	40,856 $1.43 Million
Q1 2024 May 15, 2024	SELL	$34.2 - $47.13 $942,312 - $1.3 Million	-27,553 Reduced 21.72%	99,292 $4.36 Million
Q3 2023 Nov 14, 2023	BUY	$21.07 - $29.77 $2.67 Million - $3.78 Million	126,845 New	126,845 $3.42 Million
Q2 2022 Aug 15, 2022	BUY	$8.28 - $13.88 $669,462 - $1.12 Million	80,853 Added 163.25%	130,380 $1.8 Million
Q1 2022 May 16, 2022	BUY	$11.18 - $24.02 $99,591 - $213,970	8,908 Added 21.93%	49,527 $554,000
Q4 2021 Feb 14, 2022	BUY	$20.95 - $26.88 $850,968 - $1.09 Million	40,619 New	40,619 $960,000

214

80.8M

69K

20K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.16B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.